Ketocip 2% Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective against a broad spectrum of fungal infections. It is primarily indicated for the topical treatment of superficial mycoses, including dermatophytosis, candidiasis, and pityriasis versicolor. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The cream formulation allows for targeted application to affected areas, providing localized antifungal activity with minimal systemic absorption. Ketocip 2% Cream is typically applied once or twice daily to the clean, dry affected skin for a duration prescribed by a healthcare professional, usually ranging from two to four weeks depending on the severity and type of infection. It is well tolerated, with adverse effects being generally mild and limited to local irritation, burning, or itching at the site of application. Caution is advised in patients with known hypersensitivity to ketoconazole or any cream excipients. Ketocip 2% Cream should not be used on mucous membranes or open wounds. As with all antifungal agents, adherence to the full course of treatment is essential to prevent recurrence and resistance.